abstract |
Disclosed are a composition and a method for treating a disease associated with the renin-angiotensin-aldosterone system (RAAS). Compositions useful for treating diseases associated with the renin-angiotensin-aldosterone system are provided. The composition contains a renin-angiotensin-aldosterone system inhibitor and a lipoic acid compound, as well as other therapeutic agents, and can be used in patients with hypertension, stroke, metabolic syndrome, or other renin-angiotensin-aldosterone systems. Useful for treating related diseases. The composition is also beneficial for improving patient vasodilation, reducing proteinuria, and reducing insulin resistance. Further provided are pharmaceutical compositions and methods of treatment using the compositions. [Selection figure] None |